Recombinant CTLA4 & PD1 (Vudalimab Biosimilar) antibody
The CHO Cells Monoclonal anti-CTLA4 & PD1 (Vudalimab Biosimilar) antibody (ABIN7488355) specifically detects CTLA4 & PD1 (Vudalimab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7488355
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CTLA4 & PD1 (Vudalimab Biosimilar) antibody (ABIN7488355)
Target
CTLA4 & PD1 (Vudalimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
CHO Cells
Clonality
Monoclonal
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Vudalimab Biosimilar - Anti-CTLA4,PDCD1 mAb
-
Characteristics
- Antibody Type: Bispecific ,IgG1,Kappa,Kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CTLA4 & PD1 (Vudalimab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- ANTI-PD-1/ANTI-CTLA-4 XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC
Target
-
You are here:
